Author:
Rapolienė Lolita,Taletavičienė Giedrė,Martinkėnas Arvydas
Abstract
Cardiovascular diseases are the leading cause of death globally accounting for 32 % of all global deaths. Addressing modifiable risk factors, including hypertension and stress, remains paramount in the prevention of CVD. This study aimed to assess the impact of the balneotherapy on blood pressure, heart rate, electrocardiogram parameters, utilization of antihypertensive medications, and stress levels. Methodology. Multicenter randomized controlled single-blind parallel group trial was made in 6 Lithuania resort centers. 373 participants with the stress level > 3 (10, VAS) randomly divided into 6 groups in two clusters for receiving a 6- or 11-day complex treatment using natural resources – mineral waters, peloids, salt, nature therapy; follow-up period was 6 months. The BP, HR, ECG, stress level and other parameters were analyzed in 131 participants who passed a full course of investigation. Results. The significant reduction of systolic blood pressure after treatment (7.8 mmHg) and during 6 months (7.3 mmHg) together with diastolic 5.5 after 6 month and heart rate (4 b/min) was achieved in 11-day ambulatory balneotherapy group. Increase in the activity of the parasympathetic nervous system was observed, which is reflected by an increase in the duration of the ECG indicators. The stress level decreased by up to 43%, and stress management improved by up to 41% following inpatient treatment. Conclusion. Therapy using natural resources could stand for additional cardiovascular disease prevention and management method in integrative therapy.
Reference43 articles.
1. F. Coronado, S. C. Melvin, R. A. Bell, and G. Zhao, “Global responses to prevent, manage, and control cardiovascular diseases,” Preventing Chronic Disease, Vol. 19, p. 22034, Dec. 2022, https://doi.org/10.5888/pcd19.220347
2. “Causes of death of Lithuanian residents in 2010-2022.” Health Statistics, https://www.hi.lt/php/dem13.php?dat_file=dem13.txt
3. “Confronting the world’s number one killer,” World Heart Federation, Geneva, Switzerland, 2023.
4. S. E. Kjeldsen, “Hypertension and cardiovascular risk: General aspects,” Pharmacological Research, Vol. 129, pp. 95–99, Mar. 2018, https://doi.org/10.1016/j.phrs.2017.11.003
5. “Hypertension,” World Health Organization, 2023.